Luíz Leite

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

David Fiorentino, Vincent Ho, Mark Lebwohl et al. · Journal of the American Academy of Dermatology · 2017 · 156 citations · Full text

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2021 · 112 citations · Full text

Il-23 Inhibitors, Medicine, Drug Survival +6

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

Tiago Torres, L. Puig, Ronald Vender et al. · American Journal of Clinical Dermatology · 2022 · 73 citations · Full text

Inflammation, Drug Survival, Immunology +7

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

Andrea Chiricozzi, Anna Balato, Curdin Conrad et al. · Journal of Dermatological Treatment · 2019 · 40 citations · Full text

THERAPEUTIC HOTLINE: Treatment of pityriasis rubra pilaris with etanercept

Rita Guedes, Luíz Leite · Dermatologic Therapy · 2011 · 22 citations

Rheumatology, Autoimmune Disease, Atopic Dermatitis +15